David Mcmullin - Net Worth and Insider Trading
David Mcmullin Net Worth
The estimated net worth of David Mcmullin is at least $37,134 dollars as of 2024-09-20. David Mcmullin is the Chief Commerical Officer of Aldeyra Therapeutics Inc and owns about 6,148 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $37,134. Details can be seen in David Mcmullin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Mcmullin has not made any transactions after 2019-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Mcmullin
David Mcmullin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Mcmullin owns 1 companies in total, including Aldeyra Therapeutics Inc (ALDX) .
Click here to see the complete history of David Mcmullin’s form 4 insider trades.
Insider Ownership Summary of David Mcmullin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-05 | SVP Corp. Dev. & Strategy |
David Mcmullin Latest Holdings Summary
David Mcmullin currently owns a total of 1 stock. David Mcmullin owns 6,148 shares of Aldeyra Therapeutics Inc (ALDX) as of September 5, 2019, with a value of $37,134.
Latest Holdings of David Mcmullin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALDX | Aldeyra Therapeutics Inc | 2019-09-05 | 6,148 | 6.04 | 37,134 |
Holding Weightings of David Mcmullin
David Mcmullin Form 4 Trading Tracker
According to the SEC Form 4 filings, David Mcmullin has made a total of 0 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 4,329 shares on September 5, 2019, which cost David Mcmullin around $20,260.
Insider Trading History of David Mcmullin
- 1
David Mcmullin Trading Performance
GuruFocus tracks the stock performance after each of David Mcmullin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Mcmullin is -4.36%. GuruFocus also compares David Mcmullin's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Mcmullin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Mcmullin's insider trading performs compared to the benchmark.
Performance of David Mcmullin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.68 | | | | | |
| Relative Return to S&P 500(%) | 12.49 | | | | | |
David Mcmullin Ownership Network
David Mcmullin Owned Company Details
What does Aldeyra Therapeutics Inc do?
Who are the key executives at Aldeyra Therapeutics Inc?
David Mcmullin is the SVP Corp. Dev. & Strategy of Aldeyra Therapeutics Inc. Other key executives at Aldeyra Therapeutics Inc include Chief Development Officer Stephen Machatha , See Remarks Bruce Greenberg , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Aldeyra Therapeutics Inc (ALDX) Insider Trades Summary
Over the past 18 months, David Mcmullin made no insider transaction in Aldeyra Therapeutics Inc (ALDX). Other recent insider transactions involving Aldeyra Therapeutics Inc (ALDX) include a net sale of 2,074,234 shares made by Perceptive Life Sciences Master Fund Ltd , a net sale of 57,346 shares made by Stephen Machatha , and a net sale of 37,236 shares made by Bruce Greenberg .
In summary, during the past 3 months, insiders sold 26,875 shares of Aldeyra Therapeutics Inc (ALDX) in total and bought 0 shares, with a net sale of 26,875 shares. During the past 18 months, 3,034,319 shares of Aldeyra Therapeutics Inc (ALDX) were sold and 682,265 shares were bought by its insiders, resulting in a net sale of 2,352,054 shares.
Aldeyra Therapeutics Inc (ALDX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aldeyra Therapeutics Inc Insider Transactions
David Mcmullin Mailing Address
Above is the net worth, insider trading, and ownership report for David Mcmullin. You might contact David Mcmullin via mailing address: C/o Aldeyra Therapeutics, Inc., 131 Hartwell Avenue, Suite 320, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
